Justin Schroeder, Senior Director of Marketing and Development Services at AndersonBrecon, will be speaking at the upcoming PharmaPack event in Philadelphia on June 18-19 hosted by UBM Canon.  Schroeder will participate on a the panel discussion "Serialization as part of counterfeit drug battle and supply chain security".  AndersonBrecon supports a diverse group of clients across the ethical pharmaceutical and biotech market, Over-the-Counter pharmaceutical, medical, and healthcare markets with products destined for over 100 countries around the globe.  Implementation of serialization and Track & Trace requirements across diverse global markets and package types coupled with evolving and divergent requirements requires an expert partner in impementing best-in-class systems in optimally meeting these demands.  Schroeder will discuss AndersonBrecon's experiences with existing serialization programs for commercial products as well as upcoming implementation of broader initiatives as clients prepare for pending domestic and international requirements.

For more information about the event and to register, please click here

Robert Henderson will be presenting AndersonBrecon's breakthrough Rapid Response system for Clinical Trial studies at the upcoming EPICS Spring meeting.  Henderson is a Senior Project Manager supporting AndersonBrecon's global clinical trial services.  EPICS: Equal Partners in Clinical Studies will be hosting their spring meeting on March 20th at the Westin Mount Laurel in Mount Laurel, NJ.  

For more information about the event or to register, please click here

Study published outlining the impact of compliance prompting packaging 

Published in recent weeks in the Dovepress Patient Preference and Adherence journal, the study tracked hypertensive patients receiving a single pill combination of valsartan-hydrochlorothiazide using unit dose packaging . Adherence rates for 4600-plus patients receiving the drug at Walmart pharmacies in the DiovanHCT Shellpak^TM reminder package were studied over 11 months. These were compared with adherences rates for an additional 4600-plus patients who did not receive the reminder packaging over the same period of months.

Among the study findings:

• Patients with the reminder package exhibited an 80% medication possession ration versus 73% for those without the reminder package
• Those receiving the package had a 13% higher proportion of days covered
• Patients receiving the DiovanHCT pack refilled their prescriptions four days earlier on average than the other patients.

• Patients with the reminder pack were more likely to continue their therapy over the long term.

For more information and to download the study click here:

The featured Novartis Diovan HCT package was the recipient of the Healthcare Compliance Packaging Council's (HCPC) 2010 Compliance Package of the Year.  For more information click here

AndersonBrecon Clinical Services Business Development Manager Lonie Scott will be presenting at the New England Clinical Supplies Organization (NECSO) fall meeting to highlight the value of a strategic partner in supporting successful commercialization and the Clinical-to-Commercial transition.  The event will be held in Boston on October 18th. 

For more information or to register, please click here:  http://necsomeeting.net/event.html

Often overlooked and underappreciated, pharmaceutical packaging is a crucial aspect of product commercialization—influencing everything from initial dosing to therapeutic compliance and adherence. Mike Eaddy, Vice President for Xcenda, and Justin Schroeder, Senior Director at Anderson Packaging, join the program to provide short- and long-term best practices that pharmaceutical manufacturers should consider when developing packaging for their products.

Watch Video